Bogush TA, Dudko EA, Beme AA, Bogush EA, Kim AI, Polotsky BE, et al
AucoinMLaChanceLNaidooURemyDShekdarTSayarNet al
Wegovy pill: first oral GLP-1 approved for weight loss In a landmark development, the FDA approved the Wegovy pill (oral semaglutide 25 mg) on December 22, 2025 , making it the worlds first oral GLP-1 receptor agonist approved specifically for weight management a major shift from the injection-only landscape [8]
Q5: What effect does the Inflation Reduction Acts price negotiation authority have on pharmaceutical patent strategy going forward
Newer pathway work also implicates histamine N-methyltransferase upregulation in cardiac hypertrophy and heart failure, broadening the metabolic map beyond classical energy substrates (72)